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ABSTRACT
p-Fluorophenylalanine  (PFPA),  an analogue  of phenylalanine  which may be  incorporated
into  proteins,  increases  the  duration  of mitosis.  In the  present  experiments,  based  upon
quantitative  analyses  of time-lapse  cinemicrcgraphic  films,  brief  treatments  of cells  with
PFPA are shown to  affect the duration of metaphase  in only those cells which enter division
during  or  shortly  after  treatment.  The  offspring  of cells  with prolonged  metaphases  also
tend to have  prolonged  metaphases.  Analyses of the kinetics of the appearance of prolonged
metaphases  indicate  that  some  protein  specifically  associated  with  mitosis  is  synthesized
primarily  during  a  period  which  corresponds  closely  to  G 2. The  manner  in  which  the
defect  is  passed  on to daughter  cells  indicates  that the  protein  involved  is  conserved  and
reutilized  by  daughter  cells  for  their  subsequent  divisions.  Comparable  experiments  per-
formed  with  low  concentrations  of puromycin  indicate  that  the  major  effect  of PFPA  is
due to its incorporation  into protein  rather than its  ability to  inhibit protein synthesis.  The
fact  that puromycin-induced  effects  can  also  be  passed  on  to  daughter  cells  is  interpreted
to  mean  that cells make  only specific  amounts  of some mitosis-associated proteins  and that
if a cell "inherits"  a deficiency in such protein it is not able to compensate for the deficiency.
INTRODUCTION
In the  somatic  cells  of higher  organisms,  there  is
nearly  always  a  gap  in  time  [the  so-called  G2
period  (1)]  between  the  completion  of  DNA
synthesis  and  the  entry of cells into  mitosis.  This
suggests that the G 2 period is a time when the cell
must finally  fulfill  certain  metabolic requirements
if it  is to  be properly  prepared  for  a normal divi-
sion.
It  has been known for some time that both RNA
and proteins  are  synthesized  during G2  (2-5)  and
it  has recently  been  shown that  mammalian  cells
which  are inhibited from synthesizing  these classes
of  compounds  during  this  period  will  not  enter
mitosis  (6-11).  The  purpose  of the  present  study
was  to  determine  whether  proteins  specifically
related  to  the  process  of cell  division  are  synthe-
sized  in  the  period  just  prior  to  mitosis  and  to
determine  the span of time during which such pro-
teins are made.
The experiments  presented  are  based  to  a large
extent  on  the  effects  of  p-fluorophenylalanine
(PFPA).  This compound  is  an analogue  of phenyl-
alanine which can become incorporated into newly
formed proteins in place of phenylalanine  (12-21).
In  some  instances  the  incorporation  of  the  ana-
logue has little effect  on the activity of the resultant
protein, while in  others the effect can be  profound
(16,  19,  20).  One  case which may  be quite  perti-
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FIGURE  1  Effects  of  PFPA  on the gross rate  of
protein synthesis at various times after the  begin-
ning of treatment.  )  O, 0.5 mM; O----*, 1.0
mM;  0  0,  5  mM;  G--e,  10  mM.  Each
point represents  the mean  value derived  from two
to three separate experiments.
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nent  to  problems  involving  mitotic  proteins  is
that  of  regenerating  bacterial  flagella;  the  pres-
ence  of  PFPA  does  not seriously  inhibit  the  for-
mation  of flagella, but the  flagella which  do form
in the  presence  of PFPA  are not functional  (22).
Since  flagella  and  the  mitotic  apparatus  are  in
some ways  related,  it  appeared  that PFPA  might
be  useful  for  studies  of  the  synthesis  of  mitotic
proteins.  In  fact,  Biesele  and  Jacquez  (23)  have
shown that PFPA  increases  the duration of mitosis
in cultured  tumor cells and suggested  that spindle
behavior  or  the  centromere-spindle  relationship
is  affected.  The  experiments reported  here, which
confirm  the  findings  of  the  previous  authors,
utilize  this  analogue  along  with  puromycin  for
studies on the time of synthesis of mitosis-associated
protein.  A preliminary report of some of this work
has  been presented  (24).
MATERIALS  AND  METHODS
All  experiments  were  performed  on  the  Fernandes
line of human amnion cells  (25). The culture medium,
culture  procedures,  and time-lapse  cinemicrographic
techniques  have been  described  (26,  27).  For experi-
ments  involving  cinemicrography,  cells  were  seeded
in  Rose  chambers  (28)  and  appropriate  changes  in
media  were  made  with hypodermic  needles  inserted
through the silicone  rubber gaskets.
In  our  analysis  of the  time-lapse  films,  we  define
the  beginning  of metaphase  as that time  when chro-
mosomes  are  first  observed  to  be  lined  up  on  the
equatorial  plate  of  the  spindle,  the  beginning  of
anaphase  as  that  when  chromosomes  first  begin  to
separate,  and  the  completion  of  anaphase  as  that
when  separation  of daughter  cells  is  first  seen  to be
complete  except  for  the  midbody.  (It  will  be  noted
that our criterion  of the completion of anaphase  does
not  conform  strictly  to  the  classical  one,  in  that  it
defines  anaphase  completion  as  completion  of cyto-
kinesis.)  Since  photography  was  carried  out  at  the
rate  of one  frame  per  min,  our timing  of the  above
stages  is accurate  to within  1-2 min.
Measurements  of  the  effects  of  PFPA  and  puro-
mycin on the rate of protein synthesis were performed
on  cells  grown  on  cover  slips in Leighton  tubes.  The
cover  slip  preparations  were  placed  into  tubes  of
normal  medium  (for  controls)  or of normal  medium
plus  PFPA  or  puromycin  for  appropriate  periods
of  time,  transferred  to  aliquots  of  the  same  media
containing tritiated leucine  (2 o  5  zc/ml,  5 c/mmole)
for  15  min,  and  then  fixed  in  ethanol-acetic  acid
(3:1)  and  air-dried.  The  cover  slip  preparations
were  then  rinsed  twice  in  ice-cold  50/,  trichloro-
acetic  acid  and  three  times  in  water  (10  min  each)
and  again air-dried.  Each cover  slip preparation  was
then  crushed  in  a  counting  vial,  to  which  I  ml  of
Hyamine  base was then  added. The vials were shaken
in  a  37°C  water  bath  for  1.5  hr;  scintillation  fluid
was  added,  and  the  radioactivity  was  assayed  in  a
liquid  scintillation spectrometer.
For  measurements  of the spindle,  cells  were  grown
on Leighton tube cover  slips.  After appropriate treat-
ment,  the  cover  slip  preparations  were  fixed  with
osmium  tetroxide  fumes,  washed  in  water,  stained
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FIGURE  2  Effects of PFPA on mitosis.
Ordinate  shows duration of metaphase;
abscissa, duration  of treatment starting
at time zero.  0,  duration of metaphase
in those  cells  which were  able  to enter
anaphase; t,  the time that some cells re-
mained  in metaphase  before  they died;
e,  time  of  death  of  individual  inter-
phase cells.
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very  lightly  with  azure  B,  dehydrated  in  graded
ethanols,  passed  through  two  baths  of  xylol,  and
and  mounted  in  immersion  oil.
RESULTS
Effects  of  p-Fluorophenylalanine
PROTEIN  SYNTHESIS
The  experiments  summarized  in  Fig.  I  were
performed  to  determine  the  effects  of  various
concentrations  of PFPA on  the  gross  rate of pro-
tein  synthesis.  In  the  range  between  0.5  and  10
mM  the  effect  depends  upon  both  concentration
and  time,  with maximum inhibition  at  the higher
concentrations  occurring  by  the  second  hour.  At
lower  concentrations  more  time may  be  required
to  reach  maximum  inhibition.
MITOSIS
Most  of  the  remaining  data  on  the  effects  of
PFPA  were  obtained  from  analyses  of time-lapse
cinemicrographic  films.
EFFECTS  OF  CONTINUOUS  TREATMENT:
The  first  effect  observed  after  the  beginning  of
continuous  treatment  with  1.0  mM  PFPA  is  an
increase  in  the  duration  of  metaphase  (Fig.  2),
which  becomes  fairly obvious  at  1-2  hr  after  the
beginning  of treatment.
All  cells  which  entered  metaphase  during  the
first  5  hr  after  the  beginning  of  treatment  were
capable  of completing  mitosis  even  though  most
of them  required  more  than  the usual  amount  of
time. However,  two-thirds  of those which entered
mitosis after  the fifth hour  of treatment remained
blocked  in  metaphase  for  periods  of up  to  8  hr
and  then  died.  Reversion  to  interphase  did  not
occur. The death of cells which have been  blocked
in  metaphase  for  prolonged  periods  of  time  has
also been observed to occur as a result of treatment
with  Colcemid  (29)  and  high  temperatures  (un-
published  observations)  and appears  to  be related
to  the  time the  cells  remain  in metaphase rather
than  to  the agent  causing  the blockage.
The  duration  of  anaphase  was  also  increased
(Fig.  3),  but  this  increase  did  not  appear  to  be
significant  until  about  the  fifth  hour  after  the
beginning  of treatment.  As  indicated  by  the  fre-
quency  of metaphases  at  different  times after  the
beginning  of the  experiment  (Fig.  2),  no  signifi-
cant  decrease  in  the  rate  at  which  cells  entered
metaphase  occurred  during  the  first  12  hr  of
treatment,  suggesting  that late interphase  cells are
relatively  unaffected  by  this  treatment.  A  few
interphase  cells died  but only after  the  11  Ith hour
of treatment  (Fig.  2).
So far as could be determined  by phase contrast
microscopy  of  osmium  tetroxide-fixed  material.
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the generation  times  of treated  cells  and  controls
were  essentially  identical,  indicating  again  that
other  parts  of the  cycle  are  relatively  unaffected
by this  treatment.
Since  even  in  untreated  controls  long  meta-
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which  were  "abnormally"  long  in  the  various
time  classes.  We  define  an  abnormally  long  meta-
phase, or, as later used,  an "abnormal  metaphase,"
as one  whose  duration  is more  than two  standard
5  10  15  20  deviations  above  the  mean  of the  control  as  de-
Hr  termined separately for each experiment. A normal
PFPA  on  the duration  of  ana-  metaphase  is  defined  as  one  whose  duration  is
wn in Fig. 2  which were able  to  within  two standard  deviations  of the mean of the
ate  shows duration  of  anaphase  control.  As shown  (Fig.  4),  there  are  peaks  in the
me since beginning of treatment.  histogram of the treated cultures which correspond
to  the peaks in  the continuous curve. This pattern
has  been  observed  in  many  experiments  with
nce  of  PFPA-treated  spindles various  combinations  of  treatment  times  and
,m  that  of  control  spindles.
concentrations  of PFPA.  Another  example of this cents  of the distances  between
a slight  but  significant  de-  pattern  is  presented  in  Fig.  5,  which  shows  the
a  slight  but  significant  de- effects  of  a  1  hr  treatment  with  10  mM  PFPA.
treated  spindles  (Table  I).
In  this  case  the  first  peak  is much  narrower  but
ORT  TREATMENTS:  In
ents,  colonies  of cells  whose  there  is  the  typical  return  to  the  control  level,
mitotic  times  fwere  continu-  followed  by a second  peak a generation  time later
and  a  suggestion  of a  third  peak  two  generation
time-lapse  cinemicrography
times later.
hr with medium containing
ahr  with  medium  contains  Unfortunately,  in any  single experiment or pair
of experiments,  the  sizes  of the  samples  are  rela-
I twice with normal medium
I ;  ...... 1 ,4A;.,.,,  It  tively  small,  necessitating  the grouping of the data
duration  of  the  experiment.  Both  the  normal
medium  and  the  medium  with  PFPA  contained
0.10 mM phenylalanine.  Fig.  4  shows that  a  3  hr
exposure to  1 mM PFPA  causes the mean duration
of metaphase  to  increase  to  about  30-40  min  in
those  cells  which  enter  division  within  about  10
hr  after  the  beginning  of  treatment.  This  first
increase  in  metaphase  times  will  hereafter  be
termed  the  first  peak.  Metaphases  which  occur
between  10 and  15  hr after the beginning  of treat-
ment  are normal.  A  second peak  occurs  at about
25  hr after time zero, followed  by a second decline
and  then  a  third  peak  at  about  the  50th  hour.
The  controls,  in  which  the  over-all  mean  value
for metaphase  time  was  18.1  + 0.3  min,  showed
some  variability  but  revealed  no  peaks  which
corresponded  in time or magnitude to those in the
treated populations.
TABLE  I
Effects  of p-Fluorophenylalanine (1  mM)  on Spindle
Length  in  Fernandes'  Human  Amnion  Cells  after
Varying  Times of  Treatment
Treatment  Time  Spindle length*  se
hr
PFPA  1  5.2  (-0.10
PFPA  2  5.0)  -0.07
Control  2  5.7  40.09
PFPA  4  4.7  4  (0.10
PFPA  6  4.8  -0.09
PFPA  8  4.7  ±0.05
PFPA  10  4.6  0.08
PFPA  12  4.6  -0.11
Control  12  6.1  -0.07
* In micrometer units;  1 unit =  1.48l.
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FIGrnE  4  The  effects  of  a 3 hr  treatment with 1.0  mM PFPA on the duration of  metaphase  as  a func-
tion  of  time  since  beginning  of  treatment.  Continuous  lines  indicate  mean  metaphase  times  for  cells
grouped  in  .5  hr  time  classes.  Histograms  show  the percentage  of  metaphase  cells  which  had  abnor-
mally  long durations  as  defined  in the text. Upper graphs  are  controls;  the lower  graphs are  for PFPA-
treated cells. Total measurements:  treated, 187;  controls, 285.
into 2.5 hr time classes. While this grouping allows
the  demonstration  of  the  major  effect  of PFPA,
it does not permit  a very good  chronological  reso-
lution.
In  order  to  increase  the size  of the  samples, we
grouped  first-peak  data  from  six  experiments  in
which  a  1  hr  treatment  with  10  mM  or  5  mM
PFPA  (three  experiments  for  each)  was  given.  A
second  group was made  up of the combined  data
from  five  experiments  in  which  a  1 hr  treatment
with  0.5  mM  PFPA  was  given.  For  controls  we
grouped  data  from  four  separate  control  experi-
ments.  These  three  groups  represent  data  on
samples  of  132,  215,  and  126  cells,  respectively,
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vTABLE  II
Generation times (GT) of PFPA-Treated  and Con-
trol  Cells Born at Different  Times  Relative  to  the
Beginning of Treatment
Data are  derived  from the  time-lapse  films  of
the  experiment  shown  in Fig.  4.
Treated  Controls
Time  of birth  Mean GT  + SE  Mean GT  ±SE
hr  hr  hr
-5-0  17.8  0.58  18.8  0.93
0-5  19.4  1.36  18.0  1.30
5-10  17.3  0.35  17.0  0.56
10-15  16.3  0.56  18.0  0.46
15-20  19.7  0.87  16.8  0.48
20-25  18.2  0.77  17.6  0.49
25-30  17.4  0.55  19.2  0.65
30-35  19.9  1.06  17.9  0.35
Over-all  18.1  0.28  17.9  0.18
which were divided  into ten  1-hr  age  classes. The
data  are  presented  in  terms  of  both  the  mean
metaphase  times  (Fig.  6  a)  and  the percentage  of
abnormal  metaphases  in  each  age class  (Fig. 6  ).
The  first  point to  be  considered  is the time be-
tween the beginning  of treatment  and  the appear-
ance of an effect on metaphase  cells.  As indicated,
the  mean metaphase  time  of the first  age  class  at
the  higher  concentrations  is  significantly  greater
than  in  the  controls.  In  fact,  four  cells were  ob-
served  to  enter metaphase within  15  min after the
initiation of treatment and all four had metaphase
times  between  21  and  31  min,  well  above  the
mean  for the controls.  This  is interpreted  to  mean
that there may  be less  than a  15  min lag between
the exposure of cells to PFPA  and the appearance
of an  increase  in  metaphase  times.  On  the other
hand, production of an effect' at low concentrations
required  the  1  hr  treatment  plus  an  additional
period  of  about  1  hr,  during  which  further
incorporation  of  PFPA  into  protein  from  an
endogenous  pool may  have  taken  place.
These data also show  that the peak at the higher
concentrations  is  reached  between  1  and  2  hr
after  the beginning  of treatment and  that  mainly
those  cells  which enter  division  within  about  4.5
hr  after  the  beginning  of treatment  are  affected.
Since the  effect  is  almost immediate  and  since the
duration  of treatment  is  1 hr,  it is  suggested  that
PFPA  affects  mainly  those  cells  which  are  within
a  3.5  hr  period  just  prior  to  the  beginning  of
metaphase  at the  time  of exposure  to  the  agent.
When it is considered that in these cells the average
G2  +  P time is  between  2  and 2.5  hr, with some
cells requiring  3.5  hr or more  to  get through  this
period  (30),  and  that  the distribution  of G2  +  P
times  may  have  the  same  general  form  as  the
curves  shown in  Fig.  6  (30, 31),  the data indicate
that  PFPA  may  affect  metaphase  in  only  those
cells which  were in G2 +  P when  the  agent  was
available  to  them.
The spacing  between the primary and secondary
peaks  (Figs.  4 and 5)  suggested that the daughters
of the  first-peak  cells  are  the  cells which  are  re-
sponsible  for  the  second  peak.  Since,  in  experi-
ments  like  these,  we  can  trace  individual  cells
from  one generation  to the next, it was possible  to
study  directly  whether  there  is  a  tendency  for
abnormal cells  to pass on  this trait to their daugh-
ters.  Two  kinds  of  analyses  were  performed.  The
first  was  simply  to  examine  the  tendency  for
abnormal  first-peak  cells  to  pass  on  this  trait  to
their  daughters.  Table  III  shows  that,  at  all
concentrations  and  treatment  times  tested,
daughters  of abnormal  cells  are  much  more  fre-
quently  abnormal  than daughters  of normal cells.
The second  approach was to find out what fraction
of  second-peak  cells  was  derived  from  first-peak
mothers  and  what  fraction  of  abnormal  second-
peak  cells  was  derived  from  abnormal  first-peak
mothers.  As shown  in Table  IV, most  of the  cells
which  divided  in  the  second  peak  were  derived
from mothers which divided during  the first  peak,
and  about two-thirds  of the abnormal second-peak
cells  had  abnormal  first-peak  mothers.  We  con-
clude,  therefore,  that  the  offspring  of cells which
divide  at  the time  of the  first  peak  are  generally
responsible  for  subsequent  peaks  and  that  ab-
normal  second-peak  cells tend  to be  derived  from
abnormal  first-peak  mothers.  The  fact  that  some
cells which  divided  in  the  first  peak  were  normal
but  gave rise  to  abnormal  duaghters  will  be  con-
sidered later  in this  paper.
DOUBLE  TREATMENT:  The  pattern  of  a
single  brief  treatment  followed  immediately  by  a
peak in mean metaphase times and then by another
peak  a  generation  time  later  was  observed  in
experiments  in  which  cells  were  treated  with
concentrations  of PFPA  equal  to  or  greater  than
1.0  mM.  At  0.5  m,  however,  the  second  peak
tends  to be  either  low or absent.
The following  experiment was performed  to see
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4 except  that treatment  is with  10  mM PFPA  for  1 hr. Total  measurements:
whether  two  1 hr treatments  with  0.5 mM  PFPA
spaced  20 hr apart (approximately  one generation
time)  would  enhance  the  appearance  of a  peak
one  generation  time  after  the  second  treatment.
As a control, a sister culture received only a change
in growth medium at the time of the first treatment
and  a  1  hr  exposure  to  medium  with  0.5  mM
PFPA at  the time  of the second  treatment.
Fig.  7 a shows that in the control  the only promi-
nent  peak  occurred  immediately  after  the  single
treatment with PFPA whereas in the culture which
was  exposed  twice  to  PFPA  we  observed  peaks
following  each  treatment  and,  in  addition,  a
prominent  third  peak  one  generation  time  after
the second exposure.
Effects of Puromycin
The  next  question  we  considered  was  whether
the  effect  of PFPA  is  due  to its ability  to inhibit
protein  synthesis or  to  its incorporation  into some
division-associated  protein  which  is  thereby  ren-
dered  defective.  To  do  this we  studied  the  effects
on  mitosis  of concentrations  of puromycin  which
gave  us  levels  of inhibition  of  protein  synthesis
comparable  to  those  levels  produced  by the con-
centrations  of PFPA  used  in the  previous  experi-
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FIGURE  6  Grouped first-peak  data from 1 hr treatments  with PFPA.  0  0, data grouped  together
from  three  10 mM  and  three 5  mM PFPA  experiments;  total cells,  132.  --- ,  data grouped  together
from six 0.5  mM experiments;  total cells,  215.  0  0,  data grouped  together from four control  experi-
ments; total cells,  126.
FIGURE  6  a  Mean duration  of metaphase  for each age class.
FIGURE  6  b  Percentage  of abnormal metaphases  in each age class.
ments.  Table V  compares  the  effects  of different
concentrations  of puromycin  and  PFPA  on  the
gross rate of protein synthesis  at  1 hr after the be-
ginning  of  treatment  and  indicates  that  in  our
system  I  g/ml  and  2.5  /ug/ml  puromycin  in-
hibit  protein  synthesis  to  about  the  same  extent
as  5  mM and  10  mM  PFPA,  respectively.
The effects  of 1 hr exposures  to  these concentra-
tions  on  the  duration  of  subsequent  metaphases
are shown  in Figs. 8 and  9. As can be seen,  neither
of these concentrations  produces a  prolongation of
metaphase  at  a  time  comparable  to  the  first
peak  produced  by  PFPA.  However,  starting  at
about  a generation  time after treatment,  both the
mean  metaphase  times  and  the  percentage  of
abnormal  metaphases in individual  age classes  are
increased.  First-peak  abnormalities  can  be  pro-
duced  by  puromycin,  however,  if the  concentra-
tion is high enough. In Fig.  10 we see that 25 gg/ml
puromycin  does  produce  a  prolongation  of  those
metaphases  which  appear  shortly  after  treatment
and  that  this  characteristic  is  carried  over  into
subsequent  divisions  of  these  cells,  producing
second  and  third  peaks.  Table VI  shows  that,  as
in the case of PFPA,  cells with puromycin-induced
prolonged  metaphases  have  a  greater  tendency
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I  I  I  I  I  I  I  I  I  _TABLE  III
Tendency for  Cells  with  Abnormally  Long  Meta-
phases  to  Pass on  This  Trait to  Their  ffspring
Normal  metaphases are defined  as those whose
durations are within two standard  deviations of
the  mean  of  the  controls.  Abnormal  meta-
phases  are  those  whose  durations  are  longer
than  two  standard deviations  above  the  mean
for  the  controls.  The  mother  cells  are  those
which  divided within  5  hr after  the  beginning
of various  p-fluorophenylalanine  treatments.
Abnormal mothers  Normal  mothers
No. of  No. of
Treatment  daughters  Abnormal  daughters  Abnormal
%  %
1 mM,  1 hr  6  17  31  3
1 m,  3 hr  37  35  31  19
5 m,  1 hr  14  57  24  21
10  mM,  1 hr  12  42  13  8
Over-all  69  40  99  13
to  produce  offspring  with  prolonged  metaphases
than normal  cells in  the same  age class.
DISCUSSION
The  results of  previous work  (6,  7,  9  11,  32,  33)
and  of that  presented  in  this  paper  are  all  con-
sistent  with  the hypothesis  that  one  or more pro-
teins  specifically  related  to  the  process  of division
are  synthesized just prior  to mitosis.  In  the work
presented  here  we tried  to determine  the duration
of  synthesis  of this  unidentified,  mitosis-associated
protein.  These  experiments  were  based  upon  (a)
the observation that PFPA has a relatively  selective
effect  upon  the duration  of mitosis,  (b)  the prob-
ability that  the major  mode of action  of PFPA  is
due to its incorporation into newly formed protein,
thereby  rendering  the  protein  defective,  and  (c)
the assumption  that  PFPA  affects  the duration of
mitosis in  only those cells which were  synthesizing
some  mitosis-associated  proteins  at  the  time  the
analogue was available.  A  study of the kinetics of
the appearance  of prolonged divisions in a random
population  of cells after  a short exposure to  PFPA
should  tell  us  at  what  time  during  the  mitotic
cycle  the  affected mitosis-associated  proteins were
being synthesized.
The  experiments  (i.e.  Figs. 4  and  5)  yielded  the
expected  kinds of curves,  and  an  analysis of  first-
peak  data  (Fig.  6)  suggests  that only  cells  in that
TABLE  IV
Tendencyfor Second-Peak Cells to  be Derivedfrom
Mothers Which  Divided during the  First Peak Fol-
lowing  Various  Treatments  with  p-Fluorophen-
ylalanine
Normal  and  abnormal  are  defined  as  in  Table
III.
No. of
Total  No. of  anormal
second-peak  Derived  recond-peak
cells with  from  cells with  Abnormal
traceable  first-peak  traceable  first-peak
Treatment  mothers  mothers  mothers  mothers
%  %
I  nMm,  3  hr  38  10(  12  67
5 mM,  1 hr  16  87  4  100
10 mM,  h  18  83  6  50
Over-all  72  93  22  68
part  of the  cycle  which corresponds  fairly closely
to  G2  +  P  at the  time of exposure  to  PFPA  are
affected.  In  other  words,  whatever  protein  is
involved in  the effects we observe,  the initiation of
its synthesis occurs at about the  time of completion
of  DNA  synthesis,  and  synthesis  of  this  protein
continued  to within at least  15  min prior  to meta-
phase.
These  findings  are  not  in  agreement  with  the
conclusions  of  Mueller  and  Kajiwara  (10,  34),
who studied synchronized  HeLa cells.  They found
that  continuous  treatments  with  0.5  m  PFPA
inhibited  cell division but only if cells were treated
prior to  a  4-6  hr period  after DNA  synthesis was
released  from  blockade.  They  interpreted  this  to
mean that the 4-6 hr interval after the initiation of
DNA  synthesis  "...  marks  the  end  point  for
synthesis  of  a protein  essential  for division"  (34).
Since,  in their material,  metaphase  begins  6  8  hr
after release,  this would put the end  point at about
2  hr  before  metaphase.  The  differences  between
the  two  sets  of experiments  may  be due to differ-
ences between  the cell  lines, between synchronized
and random  cells,  or to  the fact that, as shown  for
amnion  cells  (Fig.  6),  a 2 hr  lag may occur  before
a  concentration  as low  as  0.5  mM shows  an effect
on mitosis  of HeLa cells.
The fact that subsequent  peaks  are produced  by
the  daughters  of  the  cells  which  divided  at  the
time of the first peak and that the abnormal daugh-
ters  in  the  second  peak  generally  are  derived
from  abnormal  mothers  in  the  first  peak  argues
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FIGURE  7  Effect  of  double  teatnlent with 0.5  nil  PFPA on  mietaphase  times.  Continuous  lines  show
mean  metaphase  durations.  Histograms  show percentage  of  abnormal  cells  in  the individual  age  classes.
FIGURE  7  a  First pail  of arrows  indicates  a  1 hr  exposure  to fresh medium;  the  second pair  of  arrows
indicates a  I  hr exposure to 0.5  imM  PFPA. Total measurements,  362.
FIGIoJE  7  b  Both  pairs of arrows  indicate  1 hr exposures to 0.5  mIM  PFPA. Total  measurements,  308.
that the  lesion  was induced only  in  a specific  seg-
ment  of the population of cells  and  that the  lesion
is a stable one which  is passed on to daughter cells.
Further support for this comes from the experiment
in  Fig.  8,  which  shows  that  a  cumulative  effect
of a  low  concentration  could  be  built up by  short
treatments  over  two  successive  generations,  and
the presence  of third peaks  in  some of the  single-
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s5treatment  experiments  (Figs.  4,  and  perhaps  5),
which also show that defects may be inherited from
grandmothers.
Two  observations  which  need  to  be  explained
are  that  (a)  not  all  the  offspring  of  abnormal
mothers  are  abnormal  and  (b)  mothers  defined
as  normal  sometimes  give  rise  to  abnormal
daughters.  If  our  general  interpretations  of  the
data are correct, the explanations for both of these
phenomena may reside in the amount, distribution
between  daughter  cells,  and functional  role of the
PFPA-containing  protein.  If  daughter  cells  in-
herit  approximately  half  their  mitosis-associated
protein  from  their  mothers,  treatment  of  cells
during  one  cycle  can lead  to cells  in  which  only
half of the protein contains analogue  and,  a gener-
ation  time  later,  to  cells  in which  only  about  a
fourth  of the protein  contains  analogue.  Depend-
TABLE  V
Effects of Various Concentrations of p-Fluorophenyl-
alanine and Puromycin on the Gross Rate of Protein
Synthesis at I hr after the Beginning of Treatment
p-Fluorophenylalanine  Puromycin
Concentration  Inhibition  Concentration  Inhibition
mM  %  .0  tg/ml  %
0.5  6  1.0  25
1.0  11  2.5  55
5.0  33  25.0  75
10.0  51
Min
50
40
30
20
10
ing  upon  the  above  mentioned  parameters,  this
amount  of PFPA-containing  protein may or  may
not  be  enough  to  cause  daughter  cells  to  be  ab-
normal.  To explain  how normal mothers may give
rise to abnormal  daughters is a little more difficult
but, considering the variability of metaphases and,
again  depending  upon  the  above-mentioned
parameters,  one  might,  on  statistical  grounds,
expect  this phenomenon  to  occur  at a finite  fre-
quency.
The  puromycin  experiments  allow  some  in-
sight  into  the mechanism  by  which  PFPA has  its
effects  and  give further  support to  the concept  of
the  conservation  and  reutilization  of  mitosis-
associated  proteins.  As  indicated  by  the  experi-
ments shown  in  Figs.  8  and  9,  the concentrations
of  puromycin  which  inhibit  protein  synthesis  to
about  the  same  extent  as  the  concentrations  of
PFPA utilized do not produce any detectable  pro-
longation of metaphase  of those  cells which enter
division immediately after treatment. This strongly
suggests that the effects produced by PFPA are due
to its actual incorporation into proteins rather than
its ability to inhibit protein synthesis. On the other
hand,  prolongation  of metaphases  of puromycin-
treated  cells does  occur  a generation  time or more
after  treatment.  This means  that puromycin pro-
duced  a  deficiency  in  some  mitosis-associated
protein which did not show up on the first division
but did  show up in later generations.  In addition
to supporting  the concept of the conservation  and
reutilization  of mitotic  proteins,  these data  bring
0
-5  0  5  10  15  20  25  30  35  40  45  50
TIME  -Hr
FIGURE  8  Effects  of a 1 hr treatment with  1  g/ml puromycin on the duration of metaphase.  Continu-
ous  line  shows  mean  metaphase  duration  for treated  cells;  0,  mean  metaphase  duration  for  controls.
Total measurements: treated,  587; controls, 490.
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FIGURE  9  Effects  of 1-hr  treatment  with 2.5 pg/ml puromycin on the duration of metaphase.  Continu-
ous  lines  indicate  mean  metaphase  durations.  Histograms  indicate  percentage  of  abnormal  cells  in  the
various age  classes.  Total measurements,  209.
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FIGURE  10  Same  as  Fig.  9 except  that the  concentration  of puromycin  was  25 pg/ml.  Total measure-
ments,  157.
out  two  further  points. The  first  is  that  a  normal
division may take place even though  the cell has a
deficiency  which  is  great  enough  to  show  up  in
daughter  cells  a  generation  later  (Figs.  8  and 9).
The second important  point is that cells apparently
make  only  specific  amounts  of  some  mitosis-
associated  proteins  during  each  cycle  and  that  if
they  "inherit"  a  deficiency  from  their  mother
they  are unable  to compensate  for  it.  This  is  also
supported  by  the data  in  Fig.  10,  which indicate
that, if the inhibition of protein synthesis is drastic,
cells  can  be  made  deficient  enough  so  that  the
immediately  ensuing  division  will  be  prolonged,
and  that  the  effect  can  be passed  on  to  daughter
and granddaughter  cells which are not capable of
compensating  for  this  deficiency.
One  of  the  problems  in  this  kind  of  study  is
that  we  do  not  know  the  nature  of  the  protein
and  cannot  tell whether  we  are dealing  with one
protein or several  proteins. The data only indicate
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o10%TABLE  VI
Tendencyfor cells with  abnormally long metaphases
to pass on this trait to  daughter cells
The  mother  cells  are  those  which  divided
within 5  hr after  the beginning  of a  1 hr treat-
ment with  puromycin.  Normal  and  abnormal
cells are  defined  as  in Table III.
Abnormal  mothers  Normal mothers
No.  of  No.  of
Treatment  daughters  Abnormal  daughters  Abnormal
%  %
1.0  g/ml  1  100  30  3
2.5  ug/ml  6  50  27  11
25.0 pg/ml  12  25  16  6
Over-all  19  36  73  7
that  protein  is  involved  in determining  the dura-
tion of metaphase  and anaphase,  that it is  synthe-
sized  in  specific amounts  during  a specific  part of
the  mitotic  cycle,  and  that  it  is  passed  on  to
daughter  cells  and  is conserved  and reutilized  by
them  for  their  own  subsequent  divisions.  This
protein may  be a structural protein  of the mitotic
apparatus or it could be, in part at least, enzymatic
protein  similar  to that  postulated  by  Taylor  (6).
The  only  evidence  that it  might  be  a  structural
protein of the mitotic apparatus is  the observation
that treatment  of cells with  PFPA leads to a slight
decrease  in the  mean pole-to-pole  distance  of the
mitotic  spindle.  However,  since  PFPA treatment
prolongs  the  duration  of  mitosis,  this  finding
might be due to a normal shortening  of the spindle
in  late  metaphase,  as  was  reported  in untreated
cultured  newt  cells  by  Taylor  (35),  who  also
showed that  PFPA  had no effect  on the  length or
rate of formation  of the spindle.
A final  point  to  be  mentioned  is that  we  may
now be  approaching  the position  of being  able to
give the  G2  period  of the mitotic  cycle a chemical
definition.  Until  now  G2  has  been  defined  as  a
time  period  between  the  completion  of  DNA
synthesis  and the beginning of cell division. While
G2,  as mentioned  above,  is  known to  be a period
during  which  metabolic  preparations  for  cell
division are taking place, and while Kishimoto and
Lieberman  (7)  have  speculated  that  a  possible
relationship  exists  between  DNA  synthesis  and
G2  events,  there  has  been  no  evidence  of  any
unique  metabolic  step  which  occurs  exclusively
during G2 and whose  beginning and  end  coincide
with the  boundaries  of G2 . If our interpretations
are  correct,  the  findings  presented  in  this  paper
indicate that such a metabolic system may exist.
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